Corcoran Gavin
Insider CIK 1745995 · AXON EVP of R&D · VRCA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VRCA Verrica Pharmaceuticals In | A Award deriv | 2026-06-05 | 2026-06-09 | 16,000 | — | $0 | 16,000 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award deriv | 2025-06-05 | 2025-06-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VRCA Verrica Pharmaceuticals In | A Award deriv | 2025-03-31 | 2025-04-02 | 17,502 | — | $0 | 17,502 | SEC↗ |
| SIOX Sio Gene Therapies Inc. | A Award deriv | 2021-04-15 | 2021-04-19 | 244,300 | — | $0 | 244,300 | SEC↗ |
| SIOX Sio Gene Therapies Inc. | D To issuer deriv | 2021-03-17 | 2021-03-19 | 16,001 | — | $0 | 0 | SEC↗ |
| SIOX Sio Gene Therapies Inc. | A Award | 2021-03-17 | 2021-03-19 | 16,001 | — | $0 | 25,792 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | D To issuer deriv | 2020-06-12 | 2020-06-15 | 16,002 | — | $0 | 16,001 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | A Award | 2020-06-12 | 2020-06-15 | 16,002 | — | $0 | 16,002 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | F Tax w/h | 2020-06-12 | 2020-06-15 | 6,211 | $3.46 | $21.5K | 9,791 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | A Award deriv | 2020-04-15 | 2020-04-17 | 63,700 | — | $0 | 63,700 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | A Award deriv | 2020-04-15 | 2020-04-17 | 42,400 | — | $0 | 42,400 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | A Award deriv | 2019-09-21 | 2019-09-24 | 32,003 | — | $0 | 32,003 | SEC↗ |
| AXGT Axovant Sciences Ltd. | A Award deriv | 2019-04-15 | 2019-04-17 | 200,000 | — | $0 | 200,000 | SEC↗ |
| AXGT Axovant Sciences Ltd. | A Award deriv | 2019-04-15 | 2019-04-17 | 767,000 | — | $0 | 767,000 | SEC↗ |
| AXON Axovant Sciences Ltd. | A Award deriv | 2018-07-16 | 2018-07-20 | 250,000 | — | $0 | 250,000 | SEC↗ |
| AXON Axovant Sciences Ltd. | A Award deriv | 2018-07-16 | 2018-07-20 | 200,000 | — | $0 | 200,000 | SEC↗ |